Hutch News
Results per Page:
Sequence diversity in cancer-causing viruses
From the Mullins lab, University of Washington and the Vaccine and Infectious Disease Division
Breaking down HIV exclusions in cancer clinical trials
As an eligibility barrier cracks, a lung cancer patient gets a new lease on life
Lab advance brings a closer look at cancer in Africa
Live cancer cells travel 8,800 miles for deep analyses in Seattle
Meet Global Oncology's deputy program head
Key early experiences shaped Dr. Thomas Uldrick's path toward HIV-associated cancers, global health
For cancer patients with HIV, immunotherapy appears safe
Checkpoint inhibitor study suggests new treatment options for patients long excluded from cancer immunotherapy clinical trials
Good News: Dr. Jen Adair speaks on gene therapy at TEDxNashville
Celebrating faculty and staff achievements
Good News: Fred Hutch first U.S. cancer center to pledge commitment to CEO Action for Diversity & Inclusion
Celebrating faculty and staff achievements
Dr. Hootie Warren takes helm of Fred Hutch Global Oncology
Immunotherapy researcher, cancer doctor set to lead a new worldwide revolution in care
In Uganda, strengthening a partnership against cancer
A ‘compelling and inspiring visit’ yields renewed commitment by Fred Hutch, Ugandan leaders
Good News: Hutch internship program widens educational clout; outpatient clinics open in Uganda; Dr. Stefan Radtke earns DGTI award
Celebrating faculty and staff achievements
Good News at Fred Hutch
Celebrating faculty and staff achievements
‘I pray that God will help me’: Treating Kaposi sarcoma in Uganda
Researchers are partnering to better understand infection-related cancers
What Uganda is teaching us about cancer
<p>Fred Hutch-Uganda alliance builds a new cancer center on the shoulders of giants</p>
Uganda: Why ‘we’re in it for the long haul’
It’s a long way to go to study cancer, but within the East African nation of more than 30 million people the Hutchinson Center is gaining knowledge, saving lives
Hutchinson Center to build first U.S. cancer clinic and training facility in Africa thanks, in part, to a grant from USAID
Seattle and Ugandan researchers collaborate to study and treat infection-related cancers